Updated:
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. — Argentine ag-biotech firm developing HB4 drought-tolerant wheat and soy.
Bioceres Crop Solutions Corp.
Bioceres Crop Solutions Corp. was formed in 2002 in Rosario, Argentina, emerging from a group of local agricultural entrepreneurs. The firm went public on the Nasdaq in 2020 via a merger with a SPAC. Its wealth origin is tied to the founding team and early investors, including Argentine farming families. The firm operates two divisions: seed-and-traits, anchored by the HB4 technology (drought and salt tolerance developed with Raquel Chan's team at CONICET), and crop nutrition, which produces biological and mineral fertilizers. Geographic exposure spreads across Argentina, Brazil, Paraguay, Uruguay and the United States. In 2023, Bioceres launched HB4 wheat in Argentina and received approval for HB4 soy in Brazil, per company press releases. Bioceres employs over 1,000 people across South America. In October 2023, the firm raised $50 million in a private placement led by agribusiness investors to fund commercialization of HB4 wheat (per Nasdaq, October 2023). The firm's adjacent entities include the Bioceres Foundation, which supports agricultural research. Bioceres is a publicly traded corporation but retains family-office characteristics through founding-family control and a focus on long-term agricultural technology — a rare hybrid structure in which public-market access funds a concentrated, multi-decade R&D bet on climate adaptation.
General information
Firm type
Single Family Office
Year founded
2002
AUM
Undisclosed
Location
Region
Latin America
Country
Argentina
City
Rosario
Corporate office
Rosario, Santa Fe Province, Argentina
Principals
Federico Trucco
CEO
Sector focus
Frequently asked questions
Who controls investment decisions at Bioceres Crop Solutions?
CEO Federico Trucco leads the executive team, but strategic oversight comes from the board, which includes representatives of founding families and early investors. The company has a controlling shareholder group comprising Trucco and other original entrepreneurs, per public filings.
How does Bioceres source its agricultural technology?
Bioceres' core technology, HB4, was licensed from CONICET, Argentina's national scientific research council, and developed by a team led by Dr. Raquel Chan. The firm also acquires external technologies through partnerships and occasional acquisitions.
Is Bioceres structured as a family office or a corporation?
Bioceres is a publicly traded corporation (Nasdaq: BIOX). However, its objective of nurturing a single long-term technological platform — drought-tolerant seeds — aligns with a family office approach, and founding families continue to hold controlling stakes.
What investment stages does Bioceres target?
Bioceres does not invest as a traditional asset manager. The firm allocates capital internally to R&D, field trials, and regulatory approvals for its proprietary seed technologies, alongside scaling its crop-nutrition business. External capital raises (like the October 2023 private placement) fund these activities.
Which sectors does Bioceres explicitly avoid?
Bioceres focuses exclusively on agricultural biotechnology and crop inputs. It does not invest in digital health, fintech, energy, or other unrelated sectors.
Where does the underlying wealth come from?
Bioceres was founded by Argentine agricultural entrepreneurs; the wealth supporting the firm originates from the country's farming sector. The company has been a public entity since 2020, though founding families retain control.
Does Bioceres maintain philanthropic structures?
Yes, the Bioceres Foundation supports agricultural research and development, funding projects that align with the firm's focus on sustainable farming. It is a separate legal entity.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: